Skip to main navigation
Skip to search
Skip to main content
HSC Home
Home
Research units
Profiles
Publications
Sponsored Projects
Core Facilities
Search by expertise, name or affiliation
Preclinical Efficacy of Anecortave Acetate
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Preclinical Efficacy of Anecortave Acetate'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Acetate
100%
Preclinical Efficacy
100%
Neovascularization
66%
Antiangiogenic Activity
33%
Inducer
33%
Myopic Choroidal Neovascularization (mCNV)
33%
Age-related Macular Degeneration
33%
Angiostatic
33%
Pharmacology, Toxicology and Pharmaceutical Science
Anecortave
100%
Neovascularization (Pathology)
66%
Antiangiogenic
33%
Age Related Macular Degeneration
33%
Subretinal Neovascularization
33%